Cargando…
Resolution of Praziquantel
BACKGROUND: Praziquantel remains the drug of choice for the worldwide treatment and control of schistosomiasis. The drug is synthesized and administered as a racemate. Use of the pure active enantiomer would be desirable since the inactive enantiomer is associated with side effects and is responsibl...
Autores principales: | Woelfle, Michael, Seerden, Jean-Paul, de Gooijer, Jesse, Pouwer, Kees, Olliaro, Piero, Todd, Matthew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176743/ https://www.ncbi.nlm.nih.gov/pubmed/21949890 http://dx.doi.org/10.1371/journal.pntd.0001260 |
Ejemplares similares
-
Clinical Efficacy and Tolerability of Praziquantel for Intestinal and Urinary Schistosomiasis—A Meta-analysis of Comparative and Non-comparative Clinical Trials
por: Zwang, Julien, et al.
Publicado: (2014) -
Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis
por: Zwang, Julien, et al.
Publicado: (2017) -
Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg Excretion
por: Olliaro, Piero L., et al.
Publicado: (2015) -
New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel
por: Walker, Martin, et al.
Publicado: (2016) -
Open source drug discovery – A limited tutorial
por: ROBERTSON, MURRAY N., et al.
Publicado: (2014)